In addition to the FLT3L aforementioned, GM-CSF and IL-3 have been shown to protect primary FLT3-ITD AML cells and MV4-11 (a FLT3-ITD AML cell line) from crenolanib through activation of STAT5 pathway [52]. This evidence concerns the gene FLT3LG and acute myeloid leukemia.